Table 3:
Performance of the Clinical Decision Rule in the Latin American Cohort
| A: When High ICP is defined as >22 mm Hg: |
| Performance | High ICP | Normal ICP |
|---|---|---|
| Rule Positive | 61 | 49 |
| Rule Negative | 4 | 36 |
| Sensitivity | 93.9% (95% Confidence Interval [CI]: 85.0–98.3%) | |
| Specificity | 42.4% (95%CI: 31.7–53.6%) | |
| Positive Predictive Value | 55.5% (95%CI: 50.7–60.2%) | |
| Negative Predictive Value | 90.0% (95%CI: 77.1–96.0%) | |
| Positive Likelihood Ratio | 1.6 (95%CI: 1.3–2.0) | |
| Negative Likelihood Ratio | 0.2 (95%CI: 0.1–0.4) | |
| B: When High ICP is defined as >25 mm Hg: |
| Performance | High ICP | Normal ICP |
|---|---|---|
| Rule Positive | 50 | 60 |
| Rule Negative | 1 | 39 |
| Sensitivity | 98.0% (95% CI: 89.6–100.0%) | |
| Specificity | 39.4% (95%CI: 29.7– 49.7%) | |
| Positive Predictive Value | 45.5% (95%CI: 41.4–49.5%) | |
| Negative Predictive Value | 97.5% (95%CI: 84.7% to 99.6%) | |
| Positive Likelihood Ratio | 1.6 (95%CI: 1.4–1.9) | |
| Negative Likelihood Ratio | 0.1 (95%CI: 0.0–0.4) | |
| C: When High ICP is defined as >30 mm Hg: |
| Performance | High ICP | Normal ICP |
|---|---|---|
| Rule Positive | 40 | 70 |
| Rule Negative | 0 | 40 |
| Sensitivity | 100.0% (95% CI: 91.2–100.0%) | |
| Specificity | 36.4% (95%CI: 27.4–46.1%) | |
| Positive Predictive Value | 36.4% (95%CI: 33.2–39.7%) | |
| Negative Predictive Value | 100.0% (95%CI: 89.1% to 100.0%) | |
| Positive Likelihood Ratio | 1.6 (95%CI: 1.4–1.8) | |
| Negative Likelihood Ratio | 0.0 (95%CI: 0.0–0.0) | |
The area under the curve (AUC) for the logistic regression model that contains all the predictors is 0.861; P=0.49 for the Hosmer-Lemeshow goodness-of-fit test.
The AUC for the logistic regression model that contains all the predictors is 0.83; P=0.36 for the Hosmer-Lemeshow goodness-of-fit test.
The AUC for the logistic regression model that contains all the predictors is 0.82; P=0.72 for the Hosmer-Lemeshow goodness-of-fit test.